Tatiane Vilaca

16PUBLICATIONS
8CO-AUTHORS
BiomechanicsCardiology (incl. cardiovascular diseases)PharmacogenomicsGene mappingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 14, 2026
Imminent fracture risk: contributing mechanisms, risk assessment and implications for treatment.

|Jan 19, 2026
Response to Letter to the Editor regarding "The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 mo and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE project".

Tatiane Vilaca, Marian Schini, Li-Yung Lui

|Jul 28, 2025
Treatment-related changes in total hip bone mineral density are applicable to trials of varied study designs and to drugs with differing mechanisms of action: meta-regression results from the FNIH-ASBMR SABRE study.

Tatiane Vilaca, Li-Yung Lui, Marian Schini

|Apr 14, 2025
Family mapping of previously identified patients with pathogenic or likely pathogenic ALPL variants using predictive genotyping and detailed phenotyping approach: the FAME case-control study.

Tatiane Vilaca, Fatma Gossiel, Sophie Delaney

|Dec 16, 2024
The relationship between baseline bone mineral density and fracture incidence in the placebo groups of randomized controlled trials using individual patient data from the FNIH-ASBMR-SABRE project.

Marian Schini, Li-Yung Lui, Tatiane Vilaca

|Oct 17, 2024
The effects of denosumab on osteoclast precursors in postmenopausal women: a possible explanation for the overshoot phenomenon after discontinuation.

Marian Schini, Fatma Gossiel, Tanya Saini

Pageof 3

Frequent Collaborators

13 joint publications

Richard Eastell

5 joint publications

Austin Thompson

4 joint publications

Marian Schini

2 joint publications

Eric Vittinghoff